Menu
GeneBe

12-50085517-C-G

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4BS1_SupportingBS2

The NM_003076.5(SMARCD1):ā€‹c.148C>Gā€‹(p.Arg50Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000566 in 1,236,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000033 ( 0 hom., cov: 30)
Exomes š‘“: 0.0000018 ( 0 hom. )

Consequence

SMARCD1
NM_003076.5 missense

Scores

2
4
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.63
Variant links:
Genes affected
SMARCD1 (HGNC:11106): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1) The protein encoded by this gene is a member of the SWI/SNF family of proteins, whose members display helicase and ATPase activities and which are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI and has sequence similarity to the yeast Swp73 protein. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PP2
Missense variant where missense usually causes diseases, SMARCD1
BP4
Computational evidence support a benign effect (MetaRNN=0.38416055).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000033 (5/151596) while in subpopulation AMR AF= 0.000328 (5/15250). AF 95% confidence interval is 0.000129. There are 0 homozygotes in gnomad4. There are 2 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SMARCD1NM_003076.5 linkuse as main transcriptc.148C>G p.Arg50Gly missense_variant 1/13 ENST00000394963.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SMARCD1ENST00000394963.9 linkuse as main transcriptc.148C>G p.Arg50Gly missense_variant 1/131 NM_003076.5 P1Q96GM5-1

Frequencies

GnomAD3 genomes
AF:
0.0000330
AC:
5
AN:
151596
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000184
AC:
2
AN:
1085164
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
513072
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000108
Gnomad4 OTH exome
AF:
0.0000228
GnomAD4 genome
AF:
0.0000330
AC:
5
AN:
151596
Hom.:
0
Cov.:
30
AF XY:
0.0000270
AC XY:
2
AN XY:
74002
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000328
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 31, 2020The alteration results in an amino acid change:_x000D_ _x000D_ The c.148C>G (p.R50G) alteration is located in coding exon 1 of the SMARCD1 gene. This alteration results from a C to G substitution at nucleotide position 148, causing the arginine (R) at amino acid position 50 to be replaced by a glycine (G). The alteration is rare in population databases: _x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the c.148C>G alteration was observed in 0.0032% (1/31020) of total alleles studied. The altered amino acid is conserved throughout evolution:_x000D_ _x000D_ The p.R50 amino acid is conserved in available vertebrate species. The alteration is predicted tolerated by in silico modeling:_x000D_ _x000D_ The p.R50G alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Uncertain
0.16
D
BayesDel_noAF
Uncertain
-0.010
CADD
Uncertain
25
DANN
Benign
0.86
DEOGEN2
Benign
0.059
T;.;T;.
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.44
N
LIST_S2
Uncertain
0.90
D;D;D;D
M_CAP
Pathogenic
0.99
D
MetaRNN
Benign
0.38
T;T;T;T
MetaSVM
Benign
-0.30
T
MutationAssessor
Benign
1.8
L;L;.;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Pathogenic
0.95
D
PROVEAN
Benign
-0.61
N;N;N;N
REVEL
Uncertain
0.30
Sift
Benign
0.044
D;D;D;D
Sift4G
Benign
0.23
T;T;T;T
Polyphen
0.47
P;B;.;.
Vest4
0.47
MutPred
0.30
Loss of methylation at R50 (P = 0.0159);Loss of methylation at R50 (P = 0.0159);Loss of methylation at R50 (P = 0.0159);Loss of methylation at R50 (P = 0.0159);
MVP
0.65
MPC
1.5
ClinPred
0.59
D
GERP RS
3.8
Varity_R
0.27
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs954124678; hg19: chr12-50479300; API